ArticleBMC cancer2025

The clinical outcomes of adjuvant gemcitabine plus S-1 in resected pancreatic cancer: a single-center retrospective study.

Kuan-Yu Tseng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.